(19)
(11) EP 4 771 031 A1

(12)

(43) Date of publication:
08.07.2026 Bulletin 2026/28

(21) Application number: 24773227.4

(22) Date of filing: 29.08.2024
(51) International Patent Classification (IPC): 
C07K 7/06(2006.01)
A61P 25/00(2006.01)
C07K 5/083(2006.01)
A61K 38/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 7/06; C07K 5/0808; A61P 25/00; A61K 47/60
(86) International application number:
PCT/US2024/044319
(87) International publication number:
WO 2025/049670 (06.03.2025 Gazette 2025/10)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 31.08.2023 US 202363536009 P

(71) Applicant: Northwestern University
Evanston, IL 60208 (US)

(72) Inventors:
  • BURGDORF, Jeffrey S.
    Evanston, Illinois 60208 (US)
  • MOSKAL, Joseph R.
    Evanston, Illinois 60208 (US)

(74) Representative: Hoffmann Eitle 
Patent- und Rechtsanwälte PartmbB Arabellastraße 30
81925 München
81925 München (DE)

   


(54) COMPOUNDS AND METHODS FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS